CytoDyn Inc. Quarterly Common Stock, Shares, Outstanding from Q2 2011 to Q4 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
CytoDyn Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q2 2011 to Q4 2024.
  • CytoDyn Inc. Common Stock, Shares, Outstanding for the quarter ending November 30, 2024 was 1.22B shares, a 25.9% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2024 1.22B +252M +25.9% Nov 30, 2024 10-Q 2025-01-14
Q3 2024 1.22B +289M +31% Aug 31, 2024 10-Q 2024-10-15
Q2 2024 1.06B +140M +15.2% May 31, 2024 10-Q 2025-01-14
Q1 2024 990M +153M +18.3% Feb 29, 2024 10-Q 2024-04-15
Q4 2023 971M +146M +17.8% Nov 30, 2023 10-Q 2024-01-16
Q3 2023 931M +119M +14.6% Aug 31, 2023 10-Q 2023-10-23
Q2 2023 919M +199M +27.7% May 31, 2023 10-K 2024-08-15
Q1 2023 837M +123M +17.3% Feb 28, 2023 10-Q 2023-04-10
Q4 2022 825M +139M +20.3% Nov 30, 2022 10-Q 2023-01-09
Q3 2022 812M +169M +26.2% Aug 31, 2022 10-Q/A 2022-10-13
Q2 2022 720M +93.9M +15% May 31, 2022 10-K 2023-09-14
Q1 2022 713M +104M +17.1% Feb 28, 2022 10-Q 2022-04-11
Q4 2021 685M +95.6M +16.2% Nov 30, 2021 10-Q 2022-01-10
Q3 2021 644M +73.8M +12.9% Aug 31, 2021 10-Q 2021-10-12
Q2 2021 626M +107M +20.6% May 31, 2021 10-K 2022-08-15
Q1 2021 609M +138M +29.3% Feb 28, 2021 10-Q 2021-04-14
Q4 2020 590M +260M +79% Nov 30, 2020 10-Q 2021-01-08
Q3 2020 570M +186M +48.6% Aug 31, 2020 10-Q 2020-10-09
Q2 2020 519M +190M +57.6% May 31, 2020 10-K 2021-07-30
Q1 2020 471M +166M +54.6% Feb 29, 2020 10-Q 2020-04-09
Q4 2019 330M +38.9M +13.4% Nov 30, 2019 10-Q 2020-01-09
Q3 2019 383M +150M +64.1% Aug 31, 2019 10-Q 2019-10-08
Q2 2019 329M +113M +52% May 31, 2019 10-K 2020-08-14
Q1 2019 305M +95.6M +45.8% Feb 28, 2019 10-Q 2019-04-09
Q4 2018 291M +126M +76% Nov 30, 2018 10-Q 2019-01-09
Q3 2018 234M +81M +53% Aug 31, 2018 10-Q 2018-10-09
Q2 2018 217M +67.3M +45% May 31, 2018 10-K 2019-08-14
Q1 2018 209M +59.4M +39.8% Feb 28, 2018 10-Q 2018-04-09
Q4 2017 165M +26.9M +19.5% Nov 30, 2017 10-Q 2018-01-08
Q3 2017 153M +29.4M +23.9% Aug 31, 2017 10-Q 2017-10-10
Q2 2017 149M +26.1M +21.2% May 31, 2017 10-K 2018-07-27
Q1 2017 149M +85.8M +135% Feb 28, 2017 10-Q 2017-04-13
Q4 2016 138M +74.6M +117% Nov 30, 2016 10-Q 2017-01-13
Q3 2016 123M +59.7M +93.8% Aug 31, 2016 10-Q 2016-10-12
Q2 2016 123M +59.7M +93.8% May 31, 2016 10-K 2017-07-20
Q1 2016 63.6M +4.39M +7.4% Feb 29, 2016 10-Q 2016-04-13
Q4 2015 63.6M +4.91M +8.36% Nov 30, 2015 10-Q 2016-01-11
Q3 2015 63.6M +7.89M +14.2% Aug 31, 2015 10-Q 2015-10-09
Q2 2015 63.6M +7.89M +14.2% May 31, 2015 10-K 2016-07-19
Q1 2015 59.3M +3.69M +6.64% Feb 28, 2015 10-Q 2015-04-10
Q4 2014 58.7M +3.4M +6.14% Nov 30, 2014 10-Q 2015-01-12
Q3 2014 55.8M +23.7M +74% Aug 31, 2014 10-Q 2014-10-10
Q2 2014 55.8M +24.8M +80.4% May 31, 2014 10-K 2015-07-10
Q1 2014 55.6M +24.8M +80.7% Feb 28, 2014 10-Q 2014-04-11
Q4 2013 55.3M +25.4M +85% Nov 30, 2013 10-Q 2014-01-13
Q3 2013 32M +2.14M +7.17% Aug 31, 2013 10-Q 2013-10-15
Q2 2013 30.9M +2.27M +7.93% May 31, 2013 10-K 2014-07-10
Q1 2013 30.7M +2.64M +9.38% Feb 28, 2013 10-Q 2013-04-12
Q4 2012 29.9M +7.62M +34.2% Nov 30, 2012 10-Q 2013-01-14
Q3 2012 29.9M +7.61M +34.1% Aug 31, 2012 10-Q/A 2012-11-08
Q2 2012 28.6M +6.35M +28.5% May 31, 2012 10-K 2013-08-29
Q1 2012 28.1M Feb 29, 2012 10-Q 2012-04-16
Q4 2011 22.3M Nov 30, 2011 10-Q 2012-01-17
Q3 2011 22.3M Aug 31, 2011 10-Q/A 2011-11-30
Q2 2011 22.3M May 31, 2011 10-K 2012-08-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.